Dr. Masood Abu-Halima is an Associate Professor at the Institute of Human Genetics, Saarland University, Germany. His research combines computational and experimental approaches to investigate the genetic and molecular mechanisms underlying infertility and congenital disorders, with a particular focus on small RNAs and their regulatory networks in couples undergoing assisted reproductive treatments.

He specializes in whole-genome sequencing (WGS)–based analyses to identify pathogenic mutations associated with infertility in both males and females, integrating genetic variant interpretation with clinical phenotyping. His work also explores the genetic basis of congenital heart disease in children conceived naturally or through assisted reproduction, applying small RNA sequencing, transcriptomics, and WGS to improve diagnostic accuracy.

Dr. Abu-Halima holds a Habilitation (Dr. habil) and a PhD in Human Genetics from Saarland University, an MSc in Molecular Life Sciences from IUG University in Gaza, and a BSc in Laboratory Medicine from Al-Azhar University. He has authored over 40 peer-reviewed research articles and continues to advance translational genetics, reproductive health, and genomic medicine.

Prof. Mohamed Mabrouk, MD, PhD, FRCOG, is a Consultant Gynaecologist and Minimal Access Reproductive Surgeon with expertise in endometriosis and advanced endoscopic surgery. He serves as Consultant Gynaecologist and Endometriosis Surgeon at University College London Hospitals (UCLH) and Cleveland Clinic London, UK, and is Honorary Professor of Gynaecology at University College London and Adjunct Professor at the University of Southern Denmark. He also holds a Professorship in Obstetrics and Gynecology at Alexandria University, Egypt, and is President of the European Endometriosis League (EEL).

He co-founded the Endometriosis Centre at Cambridge University Hospitals and previously served as Senior Consultant at Sacred Heart Hospital, Negrar, Italy, and the Endometriosis Centre of Bologna University Hospital. He earned his PhD in Endometriosis Management from VUMC, Amsterdam, and the European Board in Obstetrics and Gynecology from Bologna University. He is a Fellow of the Royal College of Obstetricians and Gynaecologists and a past President of the Middle East Society of Gynaecological Endoscopy (MESGE).

Prof. Mabrouk is a recognized international expert in endometriosis, surgical anatomy, and minimally invasive surgery, with numerous publications and contributions to research, education, and clinical practice.

Prof. Alhalabi is the Minister of Higher Education and Scientific Research, President of the Federation of Arab Societies of OBGYN, and past President of the Middle East Fertility Society. He is a Professor of Reproductive Medicine, Genetics, and Embryology at the Faculty of Medicine, Damascus University, and serves as Head of the Assisted Reproduction Unit and Consultant Medical Director at Orient Hospital.

He graduated from Damascus University, Syria, in 1987, completed residency training in Obstetrics and Gynecology, and earned a Master’s degree and CES in 1991. He completed a research fellowship in Reproductive Endocrinology and Infertility and obtained a PhD from the University of Franche-Comté, France, in 1998.

Prof. Alhalabi has authored over 100 publications in reproductive medicine, edited ten textbooks, supervised numerous Master’s and Doctoral students, and received multiple honorary memberships and local, regional, and international awards.

Professor Khaldoun Sharif holds MBBCh (Hons), MD, MFFP, FRCOG, and FACOG qualifications and is an international expert in infertility and IVF with over 30 years of experience. A Senior Consultant in Reproductive Medicine and Surgery, he has authored more than 130 scientific publications, including textbooks, book chapters, and original research.

A Fellow of both the Royal College of Obstetricians and Gynaecologists and the American College of Obstetricians and Gynecologists, he earned his MD from the University of Birmingham, UK. He has delivered over 1,000 lectures at international conferences and workshops across Europe, North America, Asia, and the Middle East.

He spent two decades in the UK as Clinical Director of Gynaecology and Assisted Conception at Birmingham Women’s University Hospital and contributed to committees within the Human Fertilisation and Embryology Authority (HFEA). He currently serves as Clinical Director of a leading fertility program in Amman, Jordan.

Associate Prof. Moamar Al-Jefout, MD, PhD, MMED, is an Associate Professor and Consultant in Reproductive Medicine and Endoscopic Surgery at UAEU CMHS, UAE, and an Honorary Professor at Krasnoyarsk State Medical University, Russia. He is a visiting consultant in the Department of OBGYN at Kanad Hospital and serves as Director of the Clinical Program at CMHS/UAEU.

He holds an MD from the USSR, a PhD and MMED in Human Reproductive and Genetic Health from the University of Sydney, and the Jordanian Board in Obstetrics and Gynecology. He is President of the Asian Society of Endometriosis & Adenomyosis (ASAE), and a founder of the Jordan Endometriosis & Adenomyosis Group (JEAG) and the Emirates Endometriosis League (EMEL).

His clinical and research expertise focuses on endometriosis, adenomyosis, and PCOS, including prevalence, pathophysiology, diagnosis, and treatment both surgically and medically. He is a pioneer in the search for biomarkers to diagnose endometriosis and manages a wide range of benign gynecological conditions, infertility, abnormal uterine bleeding, menstrual disturbances, adolescent endocrinology, and family planning.

Dr. Ali Hellani, PhD, is a reproductive geneticist with more than 25 years of experience. He earned his doctorate in molecular genetics in France in 1999 and went on to establish the first Pre-Implantation Genetic Diagnosis (PGD) laboratory in the Gulf Region at King Faisal Specialist Hospital in Saudi Arabia in 2001. He later developed advanced genetic diagnostic laboratories across multiple institutions in the region.

In 2010, he received the Australian Board certification in Molecular Genetics and contributed significantly to the expansion of genomic diagnostic services. He founded the first genetics laboratory in the United Arab Emirates in 2012 and has authored more than 60 scientific publications in reproductive genetics.

Widely regarded as a leading clinician for genetic disease screening in the Middle East, he achieved the region’s first CAP accreditation for exome sequencing in January 2017. He currently oversees genetic laboratory operations in both Australia and the Middle East.

Dr. Huda Al-Saleh is a Senior Consultant in Obstetrics and Gynecology at the Women’s Wellness and Research Center, Hamad Medical Corporation (HMC), Qatar. She also serves as Executive Director of Quality and Patient Safety and Corporate Lead for Women’s Services across HMC hospitals.

Renowned for her leadership in quality, patient safety, ethics, and person-centered care, Dr. Al-Saleh has led national initiatives in maternal health, risk management, and AI-driven clinical transformation.

She holds advanced qualifications in healthcare management, ethics and law, quality and safety, and artificial intelligence strategy from institutions including Johns Hopkins, Harvard, and RCSI. Her work integrates strategic innovation with compassionate care, contributing to Qatar’s Vision 2030 in healthcare excellence.

Dr. Lolwa Alansari is a Senior Consultant in Obstetrics, Gynecology, and Reproductive Endocrinology at HMC and The View Hospital, and an Associate Professor of Clinical Obstetrics and Gynecology at Weill Cornell College in Qatar. She completed the Arab Board in Obstetrics and Gynecology in 2001, earned membership of the Royal College of Obstetricians and Gynaecologists (UK) from 2000–2003, and was awarded the FRCOG in 2014. She holds a Master’s in Sonography in Obstetrics and Gynecology (2008) and completed fellowships in Reproductive Endocrinology (UK, 2010–2011) and Quality & Patient Safety (2015–2016).

Dr. Alansari has held leadership roles including Residency Program Director for Obstetrics and Gynecology at HMC (2008–2011), Chair of the International Representative Committee of the RCOG in Qatar (2017–2021), and Head of the Obstetrics and Gynecology Department at Al Wakra Hospital (2019–2025). She also served as an Institutional Review Board (IRB) member from 2021–2023.

Dr. Radwan Faraj is a Senior Clinician and academic in Reproductive Medicine, serving as Clinical Professor at Qatar University and Senior Clinical Lecturer at Sheffield University. He specializes in infertility, assisted conception, pelvic ultrasound, and minimally invasive gynecologic surgery.

He previously led the Early Pregnancy Assessment Unit in the UK and directed an IVF program in Oman, contributing to advancements in reproductive care. Dr. Faraj has published over 20 scientific papers, led multiple clinical trials, and has served as an RCOG committee member and MRCOG Part 3 examiner since 2013. He is also a GMC-registered medicolegal expert with extensive experience in obstetrics and gynecology.

Dr. Taghreed Mohammed is an Associate Consultant in Obstetrics and Gynecology and a specialist in reproductive medicine at the Women’s Wellness and Research Center in Qatar. She holds the European Fellowship in Reproductive Medicine (EFRM, ESHRE/EBCOG) and completed a Fellowship in Reproductive Endocrinology and Infertility at Hamad Medical Corporation.

Dr. Taghreed is Board-certified in Obstetrics and Gynecology by the MRCOG and the Arab Board (2012). She also holds a Fellowship in Minimal Access Surgery from the World Association of Laparoscopic Surgeons and a Master of Ultrasound in Obstetrics and Gynecology from the Ian Donald University School of Medical Ultrasound. She earned her MBBS from Om-Durman Islamic University, Sudan.

Her clinical and research interests include recurrent implantation failure, endometrial receptivity, and fertility preservation. Dr. Taghreed is committed to advancing evidence-based reproductive medicine and improving patient outcomes through innovative clinical practice and research.

Dr. Alia Al-Hadi is a Senior Consultant in Obstetrics, Gynecology, and Reproductive Medicine at HMC and Director of the Fertility Preservation Program. She completed her O&G training in the UK, earning MRCOG in 2005 and FRCOG in 2018, and also completed the Arab Board for Medical Specialisation in 2006. She undertook subspecialty training in Reproductive Medicine in the UK in 2010–2011.

Dr. Al-Hadi chaired the Reproductive Medicine Department at HMC from 2019 to 2022. Her clinical and research interests focus on fertility preservation and oncofertility, as well as the management of PCOS and endometriosis-related infertility.

Dr. Keshav Malhotra is an ESHRE-certified Clinical Embryologist and Honorary Fellow of the Indian College of Reproductive Medicine. He holds multiple leadership roles, including Chairman of the Embryology SIG Aspire (2025–2027), Vice Chairman of Embryology at the Indian Society of Assisted Reproduction (2024–2026), and Chairman Elect of Embryology ISAR (2026–2028).

He serves on the Executive Committee of Alpha Scientists (2024), chairs the Certification Exam for Aspire (2024), and was an ESHRE Young Ambassador in 2021. He has also contributed as a board member of the Indian Society of Prenatal Diagnosis and Therapy (2018–2024) and as a member of Aspire’s Accreditation and Quality Control Committees (2016–2018).

Mr. Walid Maalouf was previously a Lecturer in Embryology and Course Director of the MMedSci program in Assisted Reproductive Technologies at the University of Nottingham, publishing multiple articles and supervising numerous PhD and MSc students.

He recently earned an MBA in Executive Senior Leadership and co-edited the textbook Mastering Clinical Embryology.

Dr. Necati Findikli holds a B.Sc. and M.Sc. in Molecular Biology & Genetics and a Ph.D. in Bioengineering, specializing in cell and tissue cryopreservation. He began his career in assisted reproductive technologies (ART) in 2000 and has served as Laboratory Director and Scientific Director at multiple private and hospital-based ART clinics. He currently serves as IVF Laboratory Director at Erasme Hospital in Brussels, Belgium.

An ESHRE-certified Senior Clinical Embryologist (SCE), Dr. Findikli has authored over 100 publications in peer-reviewed journals, conference proceedings, and books. His research focuses on gamete and embryo cryopreservation, reproductive genetics, and digital transformation in reproductive medicine.

He is an active member of several national and international societies, including the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE), and serves as past President and current board member of the Turkish Clinical Embryology Society and the Turkish Society of Fertility Preservation (TSFP).

Mr. Garcia Jordan is a Senior Embryologist and Laboratory Coordinator with extensive experience in developing SOPs and leading standardization processes for international IVF laboratories. His expertise includes optimizing laboratory workflows, implementing quality systems, and establishing normalization protocols across IVF units.

He is also an experienced lecturer and trainer, delivering professional development programs focused on embryology, laboratory performance, and effective communication for IVF laboratory staff.

Prof. Yacoub Khalaf is a consultant Obstetrician and Gynaecologist based in London, internationally recognized for expertise in infertility management, assisted conception, and the conservative treatment of uterine fibroids. He qualified from Assiut University, Egypt, and completed his MD in Birmingham.

He serves as Head of Fertility Services and Director of the Assisted Conception Unit (ACU) and Centre for Pre-Implantation Genetic Diagnosis (PGD) at Guy’s and St Thomas’ Hospital. He is also a Professor of Reproductive Medicine and Surgery at Guy’s and St Thomas’ Hospital and King’s College London.

Prof. Khalaf is Chair of the Scientific and Clinical Advances Advisory Committee at the HFEA, a board member of the International Society for IVF, and an advisor to the National Institute for Health and Care Excellence (NICE). He is principal investigator on multiple NIHR-funded research projects and randomized controlled trials, with publications in top journals including The Lancet, NEJM, Nature, BMJ, and Nature Cell Biology.

He has extensive experience in supervising research degrees and has been an invited speaker at numerous international conferences. Prof. Khalaf has previously served as Chair of the RCOG National Clinical Studies Group in Reproductive Medicine and Surgery, a member of the RCOG Research Committee, and Associate Editor of RBM Online. He has also appeared on national television including ITV, BBC, and Channel 4.

Dr. Ramon Aurell is a Fertility Specialist based in Spain with 22 years of experience in assisted reproduction. He graduated from the Autonomous University of Barcelona and completed specialized training in Reproductive Medicine at Hammersmith Hospital, London. He currently serves as IVF Lab Director at Teknon Hospital, Barcelona.

His clinical expertise includes IVF-ICSI, assisted hatching, and artificial insemination with donor material (IAD). Dr. Aurell has authored numerous articles in national and international journals and has actively participated in research projects, conferences, and professional sessions.

He is a member of the European Society of Human Reproduction and Embryology (ESHRE), the Spanish Association of Fertility (SEF), and the Spanish Association of Gynaecology and Obstetrics. Previously, he held leadership roles at the Dexeus University Institute, Barcelona, including Head of the Obstetrics and IVF teams, Delivery Room Coordinator, and Dexeus International Coordinator.

She is Catena work in the Division of Gynaecological Oncology of the Fondazione Policlinico Universitario A. Gemelli – IRCCS in Rome, and she is, currently, one of the referents of the Digital Hysteroscopic Clinic “CLASS Hysteroscopy Center”.

Dr. Catena is member of the Advisory Board of the European Society of Gynecological Endoscopy (ESGE) and she has contributed to the spreading of the Gynaecological Endoscopic Surgical Education and Assessment (GESEA) program within the European Society of Gynaecological Endoscopy (ESGE).

She is chair of the ESGE Special Interest Group (SIG) in “Hysteroscopy” and member of the ESGE SIG (Special Interest Group) in “Innovation in Surgery”.

Dr. Catena is the Chief Mentor of the European Certification Center in Gynaecological Endoscopic Surgery of the Fondazione Policlinico Universitario A. Gemelli – IRCCS in Rome and she is one of the Head Instructors for the European Academy of Gynecological Surgery.

Prof. Mohammed Abu Al-Ghar is a leading expert in infertility and reproductive medicine, with over 200 publications in prestigious local and international scientific journals. He has contributed to the authorship of several scientific books in the field of infertility treatment.

He is a member of numerous international and local scientific societies and the founder and first President of the Middle East Fertility Society. He has received the State Award for Scientific Excellence in 1999 and the State Award of Appreciation in Medical Sciences in 2016.

MBBCh (Hons), MD, MFFP, FRCOG, FACOG

He is a renowned international expert in infertility and IVF,
with over 30 years’ experience at the cutting-edge of the field, and over 130 publications including 11 textbooks, 19 chapters and numerous original papers.
A Senior Consultant in Reproductive Medicine & Surgery, a Fellow of the Royal College of Obstetricians & Gynaecologists (FRCOG), a Fellow of the American College of Obstetricians & Gynaecologists (FACOG) and a Doctor-of-Medicine (MD) degree holder from Birmingham University, UK.

Delivered over 1000 lectures in international conferences and workshops in the UK, USA, Canada, Japan, China, Belgium, Sweden, France, Jordan, Egypt, Saudi Arabia, Sudan, Turkey, Spain, Lebanon, Syria, Kuwait, and the UAE.
Worked in the UK for 20 years where he was the Clinical Director of Gynaecology and Assisted Conception at the Birmingham Women’s University Hospital and a member of various working groups at the Human Fertilization and Embryology Authority (HFEA).
Currently, he is the Clinical Director of the Jordan Hospital Fertility Center in Amman, Jordan

Dr. Robins completed his medical training at New York Stony Brook, followed by an OB/GYN residency at the Albert Einstein College of Medicine and a fellowship in Reproductive Endocrinology and Infertility at the University of Cincinnati. He also holds an MBA from the Kellogg School of Management at Northwestern University and currently serves as CEO of the American Society for Reproductive Medicine (ASRM).

He has held academic appointments at the University of Cincinnati, Brown University, and Northwestern University, where he served as Chief of the Division of Reproductive Endocrinology and Infertility and Director of International Medicine. His clinical and academic work in reproductive medicine includes numerous publications and funded research projects.

Dr. Robins has been an active contributor to professional societies, including ASRM and the Society for Reproductive Endocrinology and Infertility. His leadership roles have included Education Committee Chair, Secretary-Treasurer, member of the Editorial Board of Fertility and Sterility, and Board Examiner for the American Board of Obstetrics and Gynecology.

Professor Joyce Harper is a Professor of Reproductive Science and Reproductive Health, with a career spanning clinical practice, research, and academic leadership. She began her work in reproductive genetics in 1992 as part of the PGD team at Hammersmith Hospital, contributing to clinical biopsies, FISH diagnostics, and research on chromosomal abnormalities in human embryos.

She co-developed two major MSc programs at University College London—Prenatal Genetics and Fetal Medicine (1996) and Reproductive Science and Women’s Health (2002)—and currently leads the Reproductive Science and Society group. She is also the founder of Global Women Connected and Director of the Embryology and PGD Academy.

Her professional contributions include co-founding the ESHRE PGD Consortium, serving in advisory roles at the HFEA, and leading international collaborations in reproductive health education. She is additionally a co-founder of “In Tune,” a UK menopause education initiative, and “Swim Her,” a research group exploring the impact of cold-water swimming on women’s health.

Dr. Johnny Awwad, FACS, HCLD/TS(ABB), MD, is a reproductive medicine specialist with 25 years of experience. He completed his fellowship in Reproductive Endocrinology and Infertility at Massachusetts General Hospital – Harvard Medical School and later earned certification as a High-Complexity Laboratory Director in embryology and andrology.

He is a Professor of Obstetrics and Gynecology and the founding Head of the Division of Reproductive Endocrinology and Infertility at the American University of Beirut Medical Center, where he also established the institution’s cryopreservation and pre-implantation genetics programs.

With more than 110 scientific publications, he has been invited to speak at numerous international conferences. He is a past President of the Middle East Fertility Society and a recipient of the STAR Award from the American Society.

Consultant Obstetrics and Gynecology, Consultant Reproductive Health
Group Medical Director, ART Fertility Clinics

Prof. Dr. Human M. Fatemi, MD (Magna Cum Laude), is the distinguished Group Medical Director of ART Fertility Clinics in the UAE and India.
With a PhD in Reproductive Medicine and Surgery, he has earned acclaim from the European Society of Human Reproduction as well as the European Board and College of Obstetrics and Gynaecology.

As a Clinical Professor at the University of Brussels and visiting professor at multiple esteemed institutions globally, his expertise spans across the fields of Gynecology, Surgery and Reproductive Endocrinology.

With over 200+ peer-reviewed publications, a citation report of 4,000 and an H-Index of 35, he is an esteemed journal reviewer and associate editor.

His profound contributions to the field of Reproductive Medicine and Gynaecology include over 300 international conference presentations as well as numerous prestigious grants and awards.

He speaks Dutch, English, Faris (Persian), French and German.

Dr. El Samawel Hakim is a Consultant in Reproductive Medicine and Infertility with extensive clinical and academic experience in assisted reproduction. He earned his CCST in reproductive medicine and his FRCOG from the Royal College in London, and completed a master’s degree at the University of Bristol.

He received his PhD in Obstetrics and Gynecology from the University of Khartoum in 2002, along with a diploma in reproductive health from the University of Liverpool and Imperial College London in 2001. He was the first to complete the master’s program in Reproductive Medicine and Embryo Growth at the University of Bristol, graduating with distinction in 2003 and receiving the Gordon Stewart Distinguished Award.

He later obtained the Fellowship of the Royal College of Reproductive Medicine and IVF, becoming one of the few specialists in the Middle East to achieve this designation. His work includes numerous publications in international journals and invited lectures at scientific conferences, with research interests centered on immunology and ovarian function.

After two years of undergraduate training at the Semmelweis University in Budapest I studied medicine at the Freie Universität Berlin and briefly at the University of California San Francisco. In 1998 I received my MD from Berlin.
I began my residency in obstetrics and gynaecology at the Charité Berlin in 1996 and received my full registration in 2003.
During this time and again afterwards I spent a total of five years as a postdoctoral fellow jointly at Children’s Hospital and Brigham and Women’s Hospital Harvard Medical School in Boston.
Under the guidance of Judah Folkman I began working on angiogenesis and antiangiogenic therapy first in various cancer models and later in endometriosis.

In late 2005 I joined the Nuffield Department of Obstetrics and Gynaecology in Oxford first as a Clinical Fellow and then as a Clinical Lecturer and Subspecialist Trainee in Reproductive Medicine and Surgery. In 2009 I became a Senior Lecturer in Reproductive Medicine and a Honorary Consultant Gynaecologist at the Women’s Centre of the John Radcliffe Hospital in Oxford. In 2013 I became Associate Professor and in 2023 I was appointed as Professor of Reproductive Sciences.

I am the Chairperson of the Guideline Development Group of the ESHRE (European Society for Human Reproduction and Embryology) Guideline for the Management of Women with Endometriosis.

I am also a member of the current NICE Guideline Committee for Endometriosis.

Together with Prof Krina Zondervan I co-direct the Endometriosis CaRe Centre in Oxford which we founded in 2013. Our focus is to improve the genetic and molecular understanding of gynaecological conditions including endometriosis, adenomyosis, PCOS, and uterine fibroids and their associated clinical signs and symptoms.

Clinically, I am the Lead for the Endometriosis, Pelvic Pain, Infertility and Adolescent Gynaecology Services at the Oxford University Hospitals NHS Foundation Trust where I regularly treat patients in clinic and in the operating theatre. Together with my NHS colleagues, I am part of the Children and Young Adult Tissue Preservation Team helping patients with cancer and some benign diseases to preserve their fertility for the future.

Prof. Dr. Robert Brannigan is Professor and Vice Chair of Clinical Urology at Northwestern University, Feinberg School of Medicine, with a clinical and research focus on male reproductive medicine and surgery. He earned both his undergraduate and medical degrees from Northwestern University, completed Urology residency training there, and undertook a fellowship in Male Reproductive Medicine and Surgery at Baylor College of Medicine. He joined the Northwestern faculty in 1999 and currently serves as Director of the Andrology Fellowship, with over half of his former fellows now holding faculty positions at academic medical centers. He also serves as Assistant Director of Student Affairs in the Augusta Webster Office of Medical Education.

Dr. Brannigan has held leadership roles in numerous professional societies, including Past President of the Society for Male Reproduction and Urology (SMRU) and the Society for the Study of Male Reproduction (SSMR). He has served on the Examination Committee for the American Board of Urology, the Core Curriculum Committee of the American Urological Association, and the Board of Directors of the American Society for Reproductive Medicine. He is an Editorial Editor for Fertility and Sterility and has contributed to multiple peer-reviewed journals.

His clinical expertise includes male reproductive medicine, microsurgical vasectomy reversal, microsurgical varicocelectomy, micro-TESE for sperm extraction, and treatment of hypogonadism, including age-related and congenital causes such as Klinefelter’s syndrome. His research primarily focuses on fertility preservation (oncofertility) in adolescent and adult male patients with cancer.

Dr. Botros Rizk, MD, MA, FRCOG, FRCS(C), HCLD, FACOG, FACS, is a reproductive endocrinologist with extensive experience in infertility treatment and assisted reproduction. He spent 25 years as Professor and Head of Reproductive Endocrinology and Infertility at the University of South Alabama.

His academic roles include Distinguished Adjunct Professor of Obstetrics and Gynecology at Cairo University, with previous appointments at King Abdulaziz University in Jeddah, alongside visiting lectureships at internationally recognized institutions. Early in his career, he trained under Nobel Laureate Prof. Robert Edwards at Cambridge and London, and he later earned board certifications from the American Board of Obstetrics and Gynecology and the Royal College of Physicians and Surgeons of Canada.

Dr. Rizk’s work has significantly shaped modern ovarian stimulation practices, including the development of the long agonist protocol. He is widely recognized for his expertise in ovarian hyperstimulation syndrome (OHSS), endometriosis management, and advances in reproductive surgery.

A leading contributor to clinical research, he has served as principal investigator in numerous studies and is the author or editor of 28 textbooks and more than 400 peer-reviewed publications covering infertility, assisted reproduction, ultrasonography, and reproductive surgery. He is also a founding member of the Middle East Fertility Society and an early member of the European Society of Human Reproduction.

Professor Alberto gynecologist and fertility specialist with extensive international training, including a clinical observership at Yale University and a fellowship at the Centre for Reproductive Medicine (CRG) of UZ Brussels. Holds a Ph.D. and Post-Doctoral Fellowship in Reproductive Endocrinology from the University of Messina, along with two master’s degrees in Reproductive Medicine, Andrology, and Assisted Reproductive Technology.

Author of more than 68 peer-reviewed publications and book chapters, with over 1,400 citations and an h-index of 24. Earned national academic certification as Associate Professor in 2018 and Full Professor of Obstetrics and Gynecology in 2021.

Recognized internationally for contributions to reproductive medicine, with invitations to speak at more than 100 scientific meetings. Research focuses on improving outcomes in poor-prognosis patients and advancing IVF practices.

Prof. Feki, MD-PhD, is a specialist in obstetrics and gynecology, reproductive medicine, and gynecological surgery. He previously led the Stem Cell Laboratory at Geneva University Hospitals, where he contributed to deriving Switzerland’s first human embryonic stem cell and induced pluripotent stem cell lines.

He has been a faculty member at the University of Geneva’s Faculty of Medicine since 2006 and at the University of Fribourg since 2013. His academic and professional involvement includes roles within EBCOG, ESHRE, and the French Academy of Surgery.

With more than 200 scientific publications, his work spans reproductive medicine, stem cell research, and women’s health.